Latest Intraductal papillary mucinous neoplasm Stories
The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins Medicine tops the list of institutions demonstrating expertise in pancreatic cancer. TEMECULA, Calif., May 5, 2015
PARIS, March 25, 2015 /PRNewswire/ -- Investigator-Initiated DETECT Study shows benefits of using Cellvizio to safely differentiate the nature of pancreas cysts
Cancer cells are on the move in the bloodstream in the very early stage of pancreatic cancer, and can be detected before cancer is diagnosed.
Researchers from the University of Missouri have found a more accurate laboratory method for diagnosing pancreatic cancer, the fourth leading cause of cancer death in the United States.
Researchers from the Mayo Clinic recently discovered that, after removal of the entire pancreas, patients can better control their diabetes.
A team of scientists led by Johns Hopkins researchers have found that more than four in 10 people considered at high risk for hereditary pancreatic cancer have small pancreatic lesions long before they have any symptoms of the deadly disease.
Detection and removal may lower cancer risk.
Intraductal papillary mucinous neoplasm of the pancreas (IPMN) shows a wide spectrum of histological presentations, ranging from adenoma with mild atypia to adenocarcinoma.
As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons.
The levels of an inflammatory chemokine were significantly elevated in patients with pancreatic cancer who were extremely obese.
- The parings of haberdine; also, any kind of fragments.